744 related articles for article (PubMed ID: 16060119)
21. Phagocytosis and neutrophil bactericidal capacity in patients with uremia.
Wierusz-Wysocka B; Wysocki H; Michta G; Wykretowicz A; Czarnecki R; Baczyk K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):589-94. PubMed ID: 6083931
[TBL] [Abstract][Full Text] [Related]
22. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
[TBL] [Abstract][Full Text] [Related]
23. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
[TBL] [Abstract][Full Text] [Related]
24. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
25. [Phagocytic activity and oxygen radicals production of neutrophils in patients with chronic renal failure].
Takahashi K; Imada A
Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):565-74. PubMed ID: 1920936
[TBL] [Abstract][Full Text] [Related]
26. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.
Taal MW; Sigrist MK; Fakis A; Fluck RJ; McIntyre CW
Nephron Clin Pract; 2007; 107(4):c177-81. PubMed ID: 17975325
[TBL] [Abstract][Full Text] [Related]
27. Metabolic response of neutrophils to uremia and dialysis.
Haag-Weber M; Hable M; Schollmeyer P; Hörl WH
Kidney Int Suppl; 1989 Nov; 27():S293-8. PubMed ID: 2699999
[TBL] [Abstract][Full Text] [Related]
28. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
29. Acute effects of intermittent hemodialysis and sustained low-efficiency hemodialysis (SLED) on the pulmonary function of patients under mechanical ventilation.
Steinhorst RC; Vieira JM; Abdulkader RC
Ren Fail; 2007; 29(3):341-5. PubMed ID: 17497449
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis.
Kazi TG; Jalbani N; Kazi N; Jamali MK; Arain MB; Afridi HI; Kandhro A; Pirzado Z
Ren Fail; 2008; 30(7):737-45. PubMed ID: 18704823
[TBL] [Abstract][Full Text] [Related]
31. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
[TBL] [Abstract][Full Text] [Related]
32. Serum phosphate levels and mortality risk among people with chronic kidney disease.
Kestenbaum B; Sampson JN; Rudser KD; Patterson DJ; Seliger SL; Young B; Sherrard DJ; Andress DL
J Am Soc Nephrol; 2005 Feb; 16(2):520-8. PubMed ID: 15615819
[TBL] [Abstract][Full Text] [Related]
33. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.
Bain MA; Faull R; Fornasini G; Milne RW; Evans AM
Nephrol Dial Transplant; 2006 May; 21(5):1300-4. PubMed ID: 16401621
[TBL] [Abstract][Full Text] [Related]
34. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
[TBL] [Abstract][Full Text] [Related]
35. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis.
Ballow A; Gader AM; Huraib S; Mitwalli A; Al-Suleimani F; Al-Wakeel J
Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391
[TBL] [Abstract][Full Text] [Related]
36. Garenoxacin pharmacokinetics in subjects with renal impairment.
Krishna G; Gajjar D; Swan S; Marbury T; Grasela DM; Wang Z
Curr Med Res Opin; 2007 Mar; 23(3):649-57. PubMed ID: 17355746
[TBL] [Abstract][Full Text] [Related]
37. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
38. Intracellular acidification enhances neutrophil phagocytosis in chronic haemodialysis patients: possible role of CD11b/CD18.
Lin CS; Wann JG; Hsiao CW; Tai DW; Chen JS; Hsu YH; Huang HC; Chao CF
Nephrol Dial Transplant; 2008 May; 23(5):1642-9. PubMed ID: 18065787
[TBL] [Abstract][Full Text] [Related]
39. PAF-acetylhydrolase activity in plasma of patients with chronic kidney disease. Effect of long-term therapy with erythropoietin.
Papavasiliou EC; Gouva C; Siamopoulos KC; Tselepis AD
Nephrol Dial Transplant; 2006 May; 21(5):1270-7. PubMed ID: 16421163
[TBL] [Abstract][Full Text] [Related]
40. Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients.
Cuffini AM; Tullio V; Giacchino F; Mandras N; Scalas D; Belardi P; Merlino C; Carlone NA
Am J Kidney Dis; 2001 Jun; 37(6):1253-9. PubMed ID: 11382696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
